Disclosures for "Elevated Peak Width of Skeletonized Mean Diffusivity Indicates a Transient Disease-like White Matter State in Status Migrainosus"
-
Dr. Robblee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. An immediate family member of Dr. Robblee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Scottsdale Providence. The institution of Dr. Robblee has received research support from Eli Lilly. The institution of Dr. Robblee has received research support from AbbVie. The institution of Dr. Robblee has received research support from Barrow Neurological Institute. Dr. Robblee has received publishing royalties from a publication relating to health care. Dr. Robblee has received publishing royalties from a publication relating to health care.
-
Dr. Hutson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EpiFocus LLC. Dr. Hutson has received research support from Barrow Neurological Foundation.
-
Ms. Stancl has nothing to disclose.
-
Dr. Criswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie.